is semaglutide controlled substance FDA Warns on Certain Forms of Compounded FDA Ban on Compounded GLP-1

Rajive Patel (2023)

Since the approval of Wegovy for obesity in 2021 the obesity market has grown sevenfold to $24bn in 2023[3]

Both the Food and Drug Administration (FDA) and the European Medicines Agency are actively monitoring the psychiatric safety of semaglutide and similar medications after post marketing surveillance reports of depression, suicidal thoughts (ideation), and suicidal behavior in patients taking the drugs for the management of type 2 diabetes or obesity

doi: 10.3233/JAD-130584 217 WangXHLiLHlscherCPanYFChenXRQiJS

High rates of discontinuations were observed in the bima and placebo groups

Some users run longer cycles without issues, but the break helps reset receptor sensitivity